Kurome Therapeutics
Signal active
Organization
Contact Information
Overview
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Kurome Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $360.0M in funding across 24 round(s). With a team of 11-50 employees, Kurome Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Kurome Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$15.0M
Details
2
Kurome Therapeutics has raised a total of $15.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 15.0M | ||
| 2020 | Seed |
Investors
Kurome Therapeutics is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Kurome Therapeutics | - | FUNDING ROUND - Kurome Therapeutics | 15.0M |
| Queen City Angels | - | FUNDING ROUND - Queen City Angels | 15.0M |
| Kurome Therapeutics | - | FUNDING ROUND - Kurome Therapeutics | undefined |
| CincyTech | - | FUNDING ROUND - CincyTech | undefined |
Recent Activity
There is no recent news or activity for this profile.